Novo Nordisk Discloses Share Trades by Board Members and Executives
Novo Nordisk said it disclosed transactions in its shares by board members, executives and associated persons under Article 19 of the EU Market Abuse Regulation.
Novo Nordisk said it disclosed transactions in its shares by board members, executives and associated persons under Article 19 of the EU Market Abuse Regulation.